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Abstract: Cytomegaloviruses (CMVs) are known to infect many mammals, including a number
of nonhuman primates (NHPs). However, most data available arose from studies led on captive
individuals and little is known about CMV diversity in wild NHPs. Here, we analyzed a community
of wild nonhuman primates (seven species) in Taï National Park (TNP), Côte d’Ivoire, with two PCR
systems targeting betaherpesviruses. CMV DNA was detected in 17/87 primates (4/7 species).
Six novel CMVs were identified in sooty mangabeys, Campbell’s monkeys and Diana monkeys,
respectively. In 3/17 positive individuals (from three NHP species), different CMVs were co-detected.
A major part of the glycoprotein B coding sequences of the novel viruses was amplified and sequenced,
and phylogenetic analyses were performed that included three previously discovered CMVs of
western red colobus from TNP and published CMVs from other NHP species and geographic
locations. We find that, despite this locally intensified sampling, NHP CMVs from TNP are completely
host-specific, pinpointing the absence or rarity of cross-species transmission. We also show that on
longer timescales the evolution of CMVs is characterized by frequent co-divergence with their hosts,
although other processes, including lineage duplication and host switching, also have to be invoked
to fully explain their evolutionary relationships.
Keywords: cytomegalovirus; nonhuman primate; genetic diversity; host specificity; co-divergence;
Taï National Park; Côte d’Ivoire
1. Introduction
Cytomegaloviruses (CMVs; family Herpesviridae; genus Betaherpesvirinae) are viruses with a
double-stranded DNA genome of >200 kbp. In humans, CMV commonly causes asymptomatic
infection in immunocompetent individuals, but the virus is a major cause of morbidity and mortality
in newborns and immunosuppressed patients who are less able to counter primary infection or
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reactivation of latent virus [1–5]. Fever, hepatitis, pneumonia, dyspnea, gastrointestinal disorders
(diarrhea), retinitis and neurological disorder are usually the clinical signs encountered [6,7]. CMVs also
infect many nonhuman mammals, e.g., nonhuman primates (NHPs) and rodents. If and which diseases
are caused by CMVs in NHPs is, to our knowledge, not known [8].
NHP CMVs have been detected by PCR and serology or isolated in cell culture mostly from
captive individuals, i.e., hominines, including chimpanzees and orangutans [9,10] and Old World
monkey species, e.g., rhesus macaques [11], cynomolgus macaques [12], Formosan rock macaques [13],
African green monkeys [14], drills [15], and baboons [16]. In very few studies, CMVs have been
identified in wild NHPs, i.e., chimpanzees, gorillas and two species of colobus monkeys [10,17,18].
In all cases, CMVs infecting NHPs appeared to be host-specific.
However, infection studies in cell culture suggest that the species barrier for NHP CMVs is
not absolute. Rhesus CMV displays some capacity to replicate in cells of other NHPs and in cells
of human origin [19,20]. Chimpanzee CMV has been grown on human fibroblasts, lung and brain
cells [21,22] and human CMV on chimpanzee fibroblasts [23]. One possible explanation for this
discrepancy is that we know very little about CMV genetic diversity and their distribution in wild
NHPs. First insight came from a recent study carried out in Taï National Park (TNP), Côte d’Ivoire,
in which a primate predator-prey system—western chimpanzees (Pan troglodytes verus), and their
primary (western red colobus; Piliocolobus badius) and secondary prey (black-and-white colobus;
Colobus polykomos)—was used to study the risk of herpesvirus transmission between different primate
species in the wild [17]. Although the colobus monkeys were frequently infected with CMVs and
different gammaherpesviruses, there was no evidence for cross-species herpesvirus transmission,
despite frequent exposure of the chimpanzees to their herpesvirus-infected monkey prey. It was
suggested that interspecies transmission of beta- and gammaherpesviruses between members of
different NHP species is at most a rare event in the wild. In a subsequent report, sequences of human
CMVs, but no NHP CMVs, were detected in oral swabs and stool samples of human individuals living
at the border of TNP [24]. This also suggests that zoonotic events are at most rare since people in
the region still hunt and consume NHPs and are therefore also frequently exposed to infected NHP
tissues [25]. Finally, fecal samples from central chimpanzees (Pan troglodytes troglodytes) and western
lowland gorillas (Gorilla gorilla gorilla) from Odzala-Kokoua National Park (OKNP), Republic of Congo,
were shown to be positive for CMVs of chimpanzee and gorilla, respectively, but negative for CMVs of
other species [18].
Here we extended these tests for cross-species transmission of CMVs by targeting an entire
wild primate community comprised of seven primate species living syntopically in TNP. Altogether,
CMVs have been detected in six out of seven primate species including multiple CMV infections in
single individuals, but no infection of multiple host species with the same CMV.
2. Materials and Methods
2.1. Field sites and Sample Collection
Necropsy and blood samples were collected over a period of more than 10 years from deceased or
live individuals of 8 NHP species (great apes and Old World monkeys); all necropsies were performed
on carcasses detected opportunistically, i.e., no primate was culled for this project. Sampling was done
in TNP in Cote d’Ivoire, the largest protected block of tropical moist forest in West Africa. Because of
the history of anthrax and Ebola in NHP populations of TNP, full body protection suits and masks were
required and mandatory for sampling. The field samples were initially snap frozen in liquid nitrogen
and then stored at −80 ◦C at LANADA (Bingerville, Côte d’Ivoire), before being transported on dry
ice to Robert Koch Institute, Germany. Collection of NHP samples was conducted with permission of
the Ministry of Research of Côte d’Ivoire and the Office Ivoirien des Parcs et Réserves (OIPR).
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2.2. DNA Extraction
Total nucleic acid was extracted from necropsy samples (organs) and whole blood or buffy coat
using the DNAeasy blood and tissue Kit (Qiagen, Hilden, Germany), according to the manufacturer’s
instructions. DNA concentration was quantified using Nanodrop ND-1000 Spectrophotometer
(Nanodrop Technologies, Santa Clara, CA, USA) or Qubit (ThermoFischer, Waltham, MA, USA).
2.3. Generic PCR
For amplification of conserved NHP CMV UL55 and UL56 sequences, two independent generic
nested PCRs were performed targeting either UL55 (glycoprotein B) (PCR 1; Figure 1A) or UL56
(PCR 2; Figure 1A) coding sequences using degenerate primer sets (Table S1). These primers had
been designed in order to detect CMV-like betaherpesviruses, including those of NHP and humans.
Using these primers, several primate and rodent CMV-like viruses have been discovered [10,17,26].
The PCRs were performed here as published previously [17,25].
Figure 1. Map of targeted open reading frames and diagram of PCR strategy. Degenerate nested
primers (black triangles) were used to amplify part of the UL55 or UL56 open reading frame.
The amplified fragments are represented by thin solid lines between the primer binding sites (A);
Long-distance nested PCR was performed with specific primers (open triangles). The amplified
fragments are represented by dashed lines between the primer binding sites (B); Fragments amplified
in (A,B) were sequenced and assembled to a final contiguous sequence of 2.2 to 2.4 kb (C). At the top
of the figure, the genomic locus spanning open reading frames UL55 and UL56 is depicted with open
arrows. The arrowhead indicates the direction of transcription. The start of the ruler corresponds to
the first base of the ORF UL56.
2.4. Long-Distance Nested PCR
Long distance nested PCR was carried out using the TaKaRa-EX PCR kit (Takara Bio Inc., Otsu,
Japan) according to the manufacturer’s instructions, with an annealing temperature of 50 ◦C. Sequences
of primers used are listed in Table S2. PCR mix was set up on ice and contained as template 250 ng of
DNA sample that tested positive for CMV with both PCR 1 and 2. Reaction product had a length of
2.2–2.3 kb (Figure 1B).
2.5. Cytochrome B PCR
The host species assignment of CMV-positive samples was confirmed by the PCR amplification of
a fragment of the mitochondrial cytochrome b (cytb) gene, as done previously [26].
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2.6. Sequencing
All PCR products were sequenced on both strands according to Sanger’s methodology. For each
novel virus, the sequences of PCR 1, PCR 2, and long-distance PCR were assembled to a final contiguous
sequence of 2.2–2.4 kb (Figure 1).
2.7. BLAST Analysis
Blast search was undertaken in the NCBI database (www.ncbi.nlm.nih.gov/BLAST) [27].
2.8. Phylogenetic and Co-Phylogenetic Analysis
The translated amino acid UL55 sequences generated in the course of this study were aligned
with other publicly available UL55 sequences derived from NHPs using Muscle [28] as implemented
in Seaview v4 [29]. Conserved amino acid blocks were identified using gblocks (also implemented in
Seaview) [30]. The final alignment included 36 CMV sequences and one outgroup sequence (human
herpesvirus 6B; KT246127); it was comprised of 543 positions. We then performed model selection
using Prottest v2.4 [31], focusing on amino acid models available in BEAST (see below) and employing
a full maximum likelihood (ML) optimization procedure. Using the Bayesian information criterion we
identified LG + G as the model to which our data were best-fit. We then ran phylogenetic analyses using
both ML and Bayesian Markov chain Monte Carlo (BMCMC) approaches. For the ML analysis, we used
PhyML v3 [32], as implemented on the PhyML webserver [33]; tree search was performed using the
BEST algorithm and branch support was estimated using Shimodaira-Hasegawa-like approximate
likelihood ratio tests (SH-like aLRT; [34]). BMCMC analyses were run using BEAST v1.8.2 assuming
a relaxed lognormal molecular clock and modeling tree shape according to a birth-death speciation
model [35]. The output of multiple runs was examined for convergence and appropriate sampling of
the posterior with Tracer v1.6 (http://tree.bio.ed.ac.uk/software/tracer/) before being merged using
LogCombiner v1.8.2 (distributed with BEAST). The best representative tree was identified from the
posterior set of trees and annotated with TreeAnnotator v1.8.2 (also distributed with BEAST).
We downloaded the host tree from the 10kTrees webserver [36]. The 10kTrees webserver provides
pre-computed BMCMC timetrees for several taxa, including Primates.
We ran co-phylogenetic analyses using Jane v4 [37]. Jane implements a genetic algorithm to
quickly identify the most parsimonious scenarios of co-evolution, involving several types of events
(co-divergence, duplication, duplication with host switch, loss and failure to diverge). Host and
parasite phylogenies have to be provided along with the according tip mapping and an event cost
matrix. A simplified version of the CMV phylogeny was used as input, whereby single-host clades
were collapsed; to be conservative regarding the number of co-speciation events, we used the ML tree,
in which a couple of host-specific association identified by the BMCMC analysis were not supported.
The cost set we used defined co-divergence events as having a cost −1 and all non co-divergence
events as having no cost. This allows equating costs and co-divergence events. Jane was run using
the vertex-based cost mode and the parameters of the genetic algorithm were kept at their default
values (population size 100, number of generations 100). To determine the probability of observing the
inferred costs by chance, costs were also calculated on a set of 500 samples for which tip mapping was
randomized. Settings of the genetic algorithm were kept at default values.
3. Results
3.1. Detection of Cytomegaloviruses in Wild Nonhuman Primates from TNP
We tested DNA extracts from 87 NHP individuals (representing 7 NHP species; confirmed by
cytochrome b sequencing) for the presence of CMVs using a nested PCR sytem generic for members of
the herpesvirus subfamily Betaherpesvirinae (nested PCR 1; Table S1 and Figure 1A). The sequences
derived from the amplicons obtained were analyzed by BLASTN and BLASTX searches. The detection
of CMV DNA was confirmed in 17/87 NHPs: 7/37 Cercocebus atys (sooty mangabey), 1/4 Cercopithecus
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campbelli (Campbell’s monkey), 1/8 Cercopithecus diana (Diana monkey) and 9/18 Pan troglodytes verus
(western chimpanzee) (Table 1).
Names and abbreviations for newly detected viruses were formed from host species and genus
names to which the pathogen was assigned, the term “cytomegalovirus” and a consecutive number,
e.g., Cercocebus atys cytomegalovirus 1 (CatyCMV1) (Table 2).
None of the Colobus polykomos, Perodicticus potto (potto) and Piliocolobus badius, individuals tested
in this study were PCR-positive. However, positive black-and-white and red colobus individuals had
been identified in a previous study led in TNP [17], which means we have now identified CMVs in
6/7 NHP species living in this ecosystem (Table 2).
Except whole blood samples (PCR-negative), 10–28% of the organ and body fluid samples (kidney,
liver, lung, spleen, heart, gastrointestinal tract, lymph node, buffy coat) were CMV-positive in nested
PCR 1 (Table 3). In 3/17 CMV-positive individuals (from three NHP species), different viruses were
detected in different tissues. Furthermore, PtroCMV1 and PtroCMV2 were co-detected in both spleen
and liver of Pan troglodytes verus; CatyCMV1 and CatyCMV2 in both lung and liver of Cercocebus atys;
CatyCMV1 and CatyROV1 in kidney of Cercocebus atys; CcamCMV1 and CcamCMV2 in kidney and
duodenum of Cercopithecus campbelli. None of the viruses was detected in members of multiple species
(Table 4).
We applied a two-step approach to extend the short partial UL55 (glycoprotein B encoding)
sequences that had been amplified with nested PCR 1, into the adjacent coding sequence (UL56). First,
nested PCR 2 (which amplifies a short part of UL56 coding sequence; Table S1 and Figure 1a) was
applied to all CMV-positive DNA extracts. This was successful for 20/23 DNA extracts (data not
shown). Second, on the basis of the partial UL55 and UL56 sequences nested primers were specifically
selected for each novel virus (Table S2) and used for overlapping long-distance nested PCR (LD-PCR)
(Figure 1B), spanning 2.2–2.3 kb. Out of 20 extracts, 14 gave rise to the respective LD-PCR product.
These products were purified and sequenced, and the LD-PCR sequences assembled with the short
UL55 and UL56 sequences, to give final contigs of 2.23–2.39 kb that include 1.7–1.8 kb of the UL55
coding sequence (Figure 1C). These comprised all CMV-positive NHP species, and with the exception
of CatyCMV3, all CMVs detected in this study (Table 2).
The novel CMV sequences were submitted to GenBank and are available under the accession
numbers listed in Table 2.
3.2. Phylogeny and Co-Phylogeny of Cytomegaloviruses and Their Hosts
We used the new CMV sequences to investigate the diversification of CMV and more particularly
how it was influenced by their host diversification. To compare the host and CMV diversification
we generated phylogenetic trees from pre-computed resources (host phylogeny; Figure 2) or an
alignment of CMV UL55 sequences comprising our new sequences and other publicly available
sequences derived from nonhuman primates which we analyzed in a maximum likelihood or Bayesian
framework (Figures 3 and 4, respectively).
CMV phylogenetic relationships reflected their host diversification in many instances, and at
multiple taxonomic levels (Figures 2–4). Thus, CMVs infecting platyrrhines (New World monkeys)
and catarrhines (apes and Old World monkeys) formed monophyletic groups, as did CMVs infecting
members of the two catarrhine families represented in the trees (Cercopithecidae and Hominidae).
Within these families, CMVs infecting members from the subfamilies Cercopithecinae and Colobinae
were monophyletic, as were those infecting orangutans and African great apes. At an even lower
taxonomic level, CMVs infecting monkeys belonging to the tribe Cercopithecini also formed a clade.
Finally, when multiple CMVs were detected in a same host species, they generally formed monophyletic
groups, i.e., CMVs found in Cercopithecus campbelli, Colobus guereza, Piliocolobus badius or Pongo pygmaeus.
All in all, the comparison of the phylogenetic trees of CMV and their hosts therefore supported the
notion that CMV diversification was strongly influenced by the diversity or diversification of their
NHP hosts.
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Table 1. Cytomegalovirus (CMV) prevalence in nonhuman primates in Taï National Park, Côte d’Ivoire.
Common Host Name Host Species Number of Individuals Tested Number of Positives % CMV Prevalence (95% CI §) References
Western chimpanzee Pan troglodytes verus 38 (18 *) 15 (9 *) 0.39 (0.24–0.57) [17]
Sooty mangabey Cercocebus atys 37 * 7 * 0.19 (0.09–0.36)
Western red colobus Piliocolobus badius 31 (13 *) 4 (0 *) 0.13 (0.04–0.31) [17]
Black-and-white colobus Colobus polykomos 12 (3 *) 1 (0 *) 0.08 (0.01–0.40) [17]
Diana monkey Cercopithecus diana 8 * 1 * 0.12 (0.01–0.53)
Campbell’s monkey Cercopithecus campbelli 4 * 1 * 0.25 (0.01–0.78)
Potto Perodicticus potto 2 * 0 * 0 (0–0.90)
Total 132 29 22
* Individuals tested in the current study; § Confidence interval.
Table 2. Cytomegaloviruses of nonhuman primates in Taï National Park, Côte d’Ivoire.











3147 2.79 [10] FJ538485
9622 Pan troglodytes cytomegalovirus 2 PtroCMV2
2.39 Current study MG593785

















9706 Cercocebus atys cytomegalovirus 3 CatyCMV3 0.20 Current study MG593795
9720 Cercocebus atys roseolovirus 1 CatyROV1 0.22 Current study MG593796
Cercopithecus campbelli 9726 Cercopithecus campbelli cytomegalovirus 1 CcamCMV1 2.24 Current study MG593798
9727 Cercopithecus campbelli cytomegalovirus 2 CcamCMV2 2.24 Current study MG593799
Cercopithecus diana 9657 Cercopithecus diana cytomegalovirus 1 CdiaCMV1 2.24 Current study MG593790
Piliocolobus badius
6944 Piliocolobus badius cytomegalovirus 1 PbadCMV1 1.67
[17]
KF254800
6940 Piliocolobus badius cytomegalovirus 2 PbadCMV2 1.67 KF254799
4598 Piliocolobus badius cytomegalovirus 3 PbadCMV3 0.22 KF318790
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Kidney 2 2 (1) 5 (1) - 1 2 -
Liver 2 1 10 (2) 1 9 (3) 4 1
Lung 4 (1) a - 11 (3) - 7 (1) 3 1
Spleen 1 1 5 (1) 1 11 (4) 1 2
Whole blood 2 - 9 2 - - -
Buffy coat - b - 2 (1) - 1 7 -
Heart - 1 3 (1) - 1 - -
Gastrointestinal tract 2 1 (1) 3 - 1 (1) - -
Lymph node - 2 2(1) - 4 (1) 1 -
Total 13 (1) 3 (0) 50 (10) 4 (0) 37 (10) 18 (0) 4 (0)
a number of samples tested; in parentheses: number of samples CMV-positive in betaherpesvirus-generic nested PCR; b hyphen: not available.
Table 4. Cytomegaloviruses in organs and blood of nonhuman primates in Taï National Park, Côte d’Ivoire.
Host Family and Species Spleen Blood/BuffyCoat
Lymph
Node Heart Lung Kidney Liver Oesophagus Duodenum
Hominidae
Pan troglodytes verus PtroCMV1
a









Cercopithecus campbelli - - - - - CcamCMV1 - - CcamCMV2
Cercopithecus diana CdiaCMV1
Colobus polykomos - - - - - -
Perodicticus potto - - - - - -
Piliocolobus badius - - - -
a sequences of the indicated viruses were obtained from PCR products generated with degenerate nested primers that are generic for members of the Betaherpesvirinae (PCR 1); hyphen:
PCR negative.
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Figure 2. Time tree of nonhuman primate host species. This time tree was produced using a
precompiled set of posterior trees available at the 10KTrees webserver [36]. Host common names are as
follow: Aotus trivirgatus (three-striped night monkey), Cercocebus atys (sooty mangabey), Cercopithecus
campbelli (Campbell’s monkey), Cercopithecus diana (Diana monkey), Colobus guereza (guereza), Colobus
polykomos (black-and-white colobus), Gorilla gorilla (Western lowland gorilla), Macaca fascicularis
(cynomolgus monkey), Macaca mulatta (rhesus macaque), Mandrillus sphinx (mandrill), Mandrillus
leucophaeus (drill), Pan troglodytes (chimpanzee), Papio anubis (olive baboon), Papio ursinus (chacma
baboon), Piliolobus badius (western red colobus), Pongo pygmaeus (Borneo orangutan), Saimiri sciureus
(common squirrel monkey).
Figure 3. Maximum likelihood tree of partial CMV UL55 amino acid sequences. Sequences generated
for this study are bold and displayed with their sample number (accession numbers in Table 1). Internal
branches supported by Shimodaira-Hasegawa-like approximate likelihood ratio test (SH-like aLRT)
values <0.95 are grey. The common names of the hosts after which the viruses are named are given in
the legend of Figure 1.
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Figure 4. Bayesian Markov chain Monte Carlo tree of partial CMV UL55 amino acid sequences.
Sequences generated for this study are bold and displayed with their sample number (accession
numbers in Table 1). Internal branches supported by posterior probabilities <0.95 are grey. The common
names of the hosts after which the viruses are named are given in the legend of Figure 1.
However, a number of exceptions were also observed in both ML and BMCMC CMV trees.
As already pinpointed elsewhere, chimpanzees and gorillas appeared to be infected with CMVs
belonging to a minimum of two lineages, suggesting either a viral lineage duplication event in
the ancestor of African great apes or a more complex scenario involving multiple host switches
between African great ape species [10]. Our phylogenetic analyses also showed that CMVs infecting
Cercocebus atys belong to a minimum of two lineages, very distantly related to one another. In addition,
CMVs infecting members of the Cercopithecini tribe, while exhibiting a phylogenetic placement
that differed in the ML and BMCMC analyses, always disrupted the monophyly of CMVs infecting
members of the Papionini tribe. This suggests again that pure co-divergence cannot fully explain
the distribution of CMV genetic diversity in their hosts. Alternative processes, including lineage
duplication, lineage loss and host switch are required to resolve discrepancies with the host phylogeny.
To further quantify the relative weight of co-speciation and these other processes during the
diversification of NHP CMVs, we also ran explicit co-phylogenetic analyses. These analyses identified
8838 most parsimonious scenarios that all came at the same cost (−16) and all involved 16 co-speciation
events and 10 non co-speciation ones (tip mapping randomization test; p = 0).
4. Discussion
Our systematic search for CMVs in the NHP community of TNP investigated seven NHP species.
Eight CMVs were detected in four species, six of them novel and representing the first CMV detection
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in Cercocebus atys, Cercopithecus campbelli and Cercopithecus diana. Combined with the previous study
of Murthy et al. on three NHP species in TNP [17], ten distinct CMVs were identified in six NHP
species (Table 1). The only species for which no CMV could be identified was the potto but it was also
the species for which sampling intensity was the lowest (n = 2). Collectively, these results therefore
indicate that most NHP species in TNP are enzootically infected with CMVs.
In line with the moderate to high prevalence observed, we also found that three of the
17 CMV-positive NHP individuals (1 chimpanzee, 1 sooty mangabey, 1 Campbell’s monkey) were
infected with at least two different CMVs. This adds to accumulating evidence in the literature
highlighting the commonness of superinfection with different CMVs in healthy people [38–40],
chimpanzees [10,17], and rhesus macaques [41–43].
None of the eight CMVs detected in TNP infected more than one NHP species. This was also
observed in previous studies led on wild NHPs: CMVs were only detected in their respective host
species in chimpanzees, gorillas and two species of colobus monkeys [10,17,18]. However, our results
considerably reinforce the notion that cross-species CMV transmission is at most rare in extending
this observation to an entire primate community and to different modalities of NHP interactions.
For example, a number of monkeys considered in this study form polyspecific groups, which could
increase the likelihood of cross-species CMV transmission.
Our data also allowed us to investigate how the diversification patterns of CMVs and their hosts
are correlated. Even considering the phylogenetic tree which was the least favorable to co-speciation
events (the ML one) we found that co-divergence events dominate over non co-divergence events
(61% vs. 39%). Although we did not specifically investigate it, the comparison of relative divergence
dates in the CMV and NHP trees seems suggestive of a similar diversification pace (even though
not completely overlapping). It therefore seems likely that these apparent co-divergence events
might indeed represent bona fide divergence events, pinpointing a very long-term association of
these viruses and their hosts and measurable host tracking by CMVs. Interestingly, this mixture of
diversification processes dominated by co-divergence seems to be relevant to a number of viruses with
a double-stranded DNA genome, e.g., [44–46].
The combination of: (i) generally benign CMV infections in immunocompetent hosts;
(ii) possibility to induce strain-specific immunity by superinfecting seropositive individuals with
new CMVs; and (iii) apparent strong host-specificity has prompted efforts aimed at evaluating CMVs
as platforms for self-disseminating vaccines. Recently, CMVs of NHPs have notably been considered
as potential vaccine platform to protect NHPs in remote areas (and indirectly also humans) against
cross-species transmission of lethal infectious agents such as ebolaviruses [47]. Although our ecological
and evolutionary analyses of the distribution and diversification of CMVs in their natural hosts seem
broadly compatible with the abovementioned prerequisites, they also pinpoint that non co-divergence
events have left a measurable trace in the CMV phylogeny, which suggests that these approaches will
at the very least require a very careful risk assessment.
Supplementary Materials: The following is available online at www.mdpi.com/1999-4915/10/1/11/s1, Table S1:
Primers used for generic amplification of CMV UL55 and UL56 sequences; Table S2: Primers used for long-distance
PCR amplification of CMV UL55/UL56 sequences.
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